Thomas Bourgeron
Professor
University Paris Diderot
From this contributor
Expliquer la résilience à l’autisme peut faire naître de nouvelles thérapies
Explaining ‘resilience’ in autism may seed new therapies
Some individuals who have autism mutations show no signs of the condition; understanding why may lead to treatments.
Explaining ‘resilience’ in autism may seed new therapies
Questions for Thomas Bourgeron: In search of ‘second hits’
Taking a close look at people who have a mutation in a known autism gene may reveal why these people often have vastly different characteristics.
Questions for Thomas Bourgeron: In search of ‘second hits’
Explore more from The Transmitter
Largest leucovorin-autism trial retracted
A reanalysis of the data revealed errors and failed to replicate the results.
Largest leucovorin-autism trial retracted
A reanalysis of the data revealed errors and failed to replicate the results.
NIH scraps policy that classified basic research in people as clinical trials
The policy aimed to increase the transparency of research in humans but created “a bureaucratic nightmare” for basic neuroscientists.
NIH scraps policy that classified basic research in people as clinical trials
The policy aimed to increase the transparency of research in humans but created “a bureaucratic nightmare” for basic neuroscientists.
Cell atlas cracks open ‘black box’ of mammalian spinal cord development
The atlas details the genetics, birth dates and gene-expression signatures of roughly 150 neuron subtypes in the dorsal horn of the mouse spinal cord.
Cell atlas cracks open ‘black box’ of mammalian spinal cord development
The atlas details the genetics, birth dates and gene-expression signatures of roughly 150 neuron subtypes in the dorsal horn of the mouse spinal cord.